Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 1918-1932
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1918
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1918
Figure 1 Transcriptional factor III A expression in colorectal cancer and survival analysis of patients with colorectal cancer.
A: Transcriptional factor III A (GTF3A) expression in adjacent normal, colorectal cancer (CRC), and metastatic tissues were detected using immunohistochemical staining. The grading standards were: (1) Negative, a, scored as 0; (2) Weakly positive, b, scored as 1; (3) Moderately positive, c, scored as 2; and (4) Strongly positive, d, scored as 3. Scale bar, 50 μm; B: GTF3A expression in adjacent normal, CRC, and metastatic tissues was quantified using semi-quantitative histological score. Scored dots expression groups were statistically analyzed using unpaired t test; C: Overall survival of patients with GTF3A negative (n = 25) or GTF3A positive (n = 56) expression was analyzed by log-rank (Mantel-Cox) test. bP < 0.01; cP < 0.001. GTF3A: Transcriptional factor III A; HSCORE: Semi-quantitative histological score.
- Citation: Wang J, Tan Y, Jia QY, Tang FQ. Transcriptional factor III A promotes colorectal cancer progression by upregulating cystatin A. World J Gastrointest Oncol 2022; 14(10): 1918-1932
- URL: https://www.wjgnet.com/1948-5204/full/v14/i10/1918.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.1918